No results for ‘’
Anupam Rasayan India Ltd
NSE: ANURAS BSE: 543275
₹1207.80
(0.25%)
Wed, 05 Aug 2026, 07:55 am
Market Cap (in Cr)13736.37
PE Ratio80.07
Dividend0.12
Health Technology
Pharmaceuticals: Major
24.5KCompany History
1984
- The Company was initially formed as a partnership firm as ‘Anupam Rasayan’ to commence the business of manufacture and sale of chemicals
- The partnership firm was registered under the Indian Partnership Act, 1932 with the Registrar of Firms, Surat.
1992
- Mr. Anand S Desai was inducted as a partner in the firm.
2001
- Ms. Mona A Desai, along with Mr. Rohan Ashwin Desai and Mr. Aman Ashwin Desai were admitted as partners in the firm.
2003
- The partnership firm was converted into a joint stock company and was registered as a public limited company under the Companies Act 1956 under the name of ‘Anupam Rasayan India Limited’
- Received the certificate of commencement of business, issued by the Assistant Registrar of Companies, Gujarat.
2010
- Started supplying specialty chemicals to Syngenta Asia Pacific Pte Ltd in Singapore.
2014
- Purchased the entire leasehold rights over the property and manufacturing facility at Plot No. 907/3, Jhagadia, Gujarat from Krishna Solvechem Limited.
2015
- Received consent to establish for setting up the industrial plant at Jhagadia Unit-5 from GPCB.
2016
- KPI LLC made its first tranche of investment in the Company.
2017
- Commenced the supply of specialty chemicals to Sumitomo Chemical Company Limited in Japan.
2018
- KPI LLC invested USD 35 million as an external commercial borrowing in the Company.
2019
- Received consolidated consents and authorisation for Jhagadia Unit-5 and Sachin Unit-6, both from GPCB.
2020
- Received consolidated consent and authorisation for the research and development centre on Sachin Unit-6 from GPCB.
2022
- Anupam Rasayan India bags order worth $95 million from a crop protection firm.